{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:28:22Z","timestamp":1792985302127,"version":"4.5.0"},"reference-count":92,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin","award":["DS14"],"award-info":[{"award-number":["DS14"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Tuberculosis (TB) remains one of the leading causes of mortality worldwide, exacerbated by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains. In the pursuit of novel therapeutic strategies, thiazolidin-4-one derivatives have gained significant attention due to their structural diversity and broad-spectrum biological activities. This review provides a comprehensive summary of recent advances (2021\u2013present) in the synthesis, structure\u2013activity relationship (SAR), and mechanisms of action of thiazolidin-4-one derivatives as promising antitubercular agents. A detailed discussion of synthetic pathways is presented, including classical and multi-component reactions leading to various subclasses such as thiazolidine-2,4-diones, rhodanines, and pseudothiohydantoins. The SAR analysis highlights key functional groups that enhance antimycobacterial activity, such as halogen substitutions and heterocyclic linkers, while molecular docking and in vitro studies elucidate interactions with key Mtb targets including InhA, MmpL3, and DNA gyrase. Several compounds demonstrate potent inhibitory effects with MIC values lower than or comparable to first-line TB drugs, alongside favorable cytotoxicity profiles. These findings underscore the potential of thiazolidin-4-one scaffolds as a valuable platform for the development of next-generation antitubercular therapeutics.<\/jats:p>","DOI":"10.3390\/molecules30102201","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:37:13Z","timestamp":1747633033000},"page":"2201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021\u2013Present)"],"prefix":"10.3390","volume":"30","author":[{"given":"Wiktoria","family":"Drza\u0142","sequence":"first","affiliation":[{"name":"Students Research Group, Department of Organic Chemistry, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-7470","authenticated-orcid":false,"given":"Nazar","family":"Trotsko","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"ref_1","unstructured":"(2024). Global Tuberculosis Report 2024, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e02327-23","DOI":"10.1128\/spectrum.02327-23","article-title":"Antimicrobial and anti-biofilm activity of a thiazolidinone derivative against Staphylococcus aureus in vitro and in vivo","volume":"12","author":"Zhao","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Trotsko, N., Kosikowska, U., Paneth, A., Plech, T., Malm, A., and Wujec, M. (2018). Synthesis and antibacterial activity of new thiazolidine-2,4-dione-based chlorophenylthiosemicarbazone hybrids. Molecules, 23.","DOI":"10.3390\/molecules23051023"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jsps.2018.01.016","article-title":"Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl\/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties","volume":"26","author":"Trotsko","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"138127","DOI":"10.1016\/j.molstruc.2024.138127","article-title":"Discovery of novel thiazolidinone-1,2,3-triazole hybrids with (D)-limonene skeleton as anticancer agents: Design, synthesis and biological evaluation","volume":"1308","author":"Mukhrish","year":"2024","journal-title":"J. Mol. Struct."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Szczepa\u0144ski, J., Khylyuk, D., Korga-Plewko, A., Michalczuk, M., Ma\u0144dziuk, S., Iwan, M., and Trotsko, N. (2024). Rhodanine-piperazine hybrids as potential VEGFR, EGFR, and HER2 targeting anti-breast cancer agents. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212401"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kamboj, P., Imtiyaz, K., Rizvi, M.A., Nath, V., Kumar, V., Husain, A., and Amir, M. (2024). Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-59063-x"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14756366.2017.1387543","article-title":"Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives","volume":"33","author":"Trotsko","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mekhlef, Y.O., AboulMagd, A.M., and Gouda, A.M. (2023). Design, synhtesis, molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents. Bioorg. Chem., 133.","DOI":"10.1016\/j.bioorg.2023.106411"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Haroun, M., Petrou, A., Tratrat, C., Kolokotroni, A., Fesatidou, M., Zagaliotis, P., Gavalas, A., Venugopala, K.N., Sreeharsha, N., and Nair, A.B. (2022). Discovery of 5-methylthiazole-thiazolidinone conjugates as potential anti-inflammatory agents: Molecular target indetification and in silico studies. Molecules, 27.","DOI":"10.3390\/molecules27238137"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","article-title":"Thiazolidinone\/thiazole based hybrids\u2014New class of antitrypanosomal agents","volume":"174","author":"Kryshchyshyn","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Trotsko, N., Bekier, A., Paneth, A., Wujec, M., and Dzitko, K. (2019). Synthesis and in vitro anti-Toxoplasma gondii activity of novel thiazolidin-4-one derivatives. Molecules, 24.","DOI":"10.3390\/molecules24173029"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113266","DOI":"10.1016\/j.ejmech.2021.113266","article-title":"Antitubercular properties of thiazolidin-4-ones\u2014A review","volume":"215","author":"Trotsko","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Prasad, M.S., Bhole, R.P., Khedekar, P.B., and Chikhale, R.V. (2021). Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery. Bioorg. Chem., 115.","DOI":"10.1016\/j.bioorg.2021.105242"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152607781001763","article-title":"Mycobacterium tuberculosis DNA gyrase as a target for drug discovery","volume":"7","author":"Mdluli","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"112390","DOI":"10.1016\/j.ejmech.2020.112390","article-title":"MmpL3 inhibitors as antituberculosis drugs","volume":"200","author":"Shao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1042\/BST20190950","article-title":"Targeting MmpL3 for anti-tuberculosis drug development","volume":"48","author":"Bolla","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e202200618","DOI":"10.1002\/cmdc.202200618","article-title":"Thiazolidinone-heterocycle frameworks: A concise review of their pharmacological significance","volume":"18","author":"Seboletswe","year":"2023","journal-title":"ChemMedChem"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bioorg.2017.10.014","article-title":"Synthetic and medicinal perspective of thiazolidinones: A review","volume":"75","author":"Manjal","year":"2017","journal-title":"Bioorg. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Trotsko, N. (2024). Thiazolidin-4-ones as a promising scaffold in the development of antibiofilm agents\u2014A review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010325"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mech, D., Kurowska, A., and Trotsko, N. (2021). The bioactivity of thiazolidin-4-ones: A short review of the most recent studies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111533"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e202400147","DOI":"10.1002\/open.202400147","article-title":"Medicinal perspective of 2,4-thiazolidinediones derivatives: An insight into recent advancements","volume":"13","author":"Gupta","year":"2024","journal-title":"ChemistryOpen"},{"key":"ref_23","first-page":"11","article-title":"Synthesis of 3-furfurylrhodanine and its 5-arylidene derivatives","volume":"6","author":"Tarasevicius","year":"1966","journal-title":"Farmatsevtychnyi Zhurnal"},{"key":"ref_24","first-page":"40","article-title":"Synthesis of methionine-based rhodanines","volume":"1","author":"Yakubich","year":"1984","journal-title":"Farmatsevtychnyi Zhurnal"},{"key":"ref_25","first-page":"58","article-title":"Synthesis of asparagine acid-based rhodanines","volume":"5","author":"Yakubich","year":"1983","journal-title":"Farmatsevtychnyi Zhurnal"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ardp.19873200410","article-title":"Synthese und reaktionen von 3-aminorhodaninen","volume":"320","author":"Hanefeld","year":"1987","journal-title":"Arch. Pharm."},{"key":"ref_27","unstructured":"Kinugawa, J., and Nagase, H. (2025, May 16). 2-Thioxo-4-thiazolidinone-5-acetic Acid Derivatives. JP 41016285 B 14 September 1966. Available online: https:\/\/scifinder-n.cas.org\/searchDetail\/reference\/6827c08638bc51022663f787\/referenceDetails."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/60600510","article-title":"Reaction of 5-aroylmethylene-3-benzyl-4-oxo-2-thioxo-1,3-thiazolidines with nitrile oxides","volume":"6","author":"Kandeel","year":"2001","journal-title":"Molecules"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1248\/cpb.21.279","article-title":"Fungicides XXII. Reaction of dimethyl acetylenedicarboxylate with dithiocarbamates, thiolcarbamates, thiosemicarbazides, and thiosemicarbazones","volume":"21","author":"Nagase","year":"1973","journal-title":"Chem. Pharm. Bull."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14756366.2017.1316494","article-title":"Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives","volume":"32","author":"Carradori","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmech.2014.08.046","article-title":"Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii","volume":"86","author":"Bizzarri","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.bmcl.2010.03.013","article-title":"Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones","volume":"20","author":"Pan","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejmech.2012.06.052","article-title":"Synthesis, characterization and structure optimization of a series of thiazolidinone derivatives as Entamoeba histolytica inhibitors","volume":"55","author":"Mushtaque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/jo01073a613","article-title":"2-Imino-4-oxo-5-thiazolidineacetic acid and its derivatives","volume":"25","author":"Arakelian","year":"1960","journal-title":"J. Org. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/slct.201802366","article-title":"Highly efficient, combinatorial and catalyst-free approach for the synthesis of 2-benzylidenehydrazono-3-phenyl-4-thiazolidinone-5-acetates in ethanol","volume":"4","author":"Jangale","year":"2019","journal-title":"ChemistrySelect"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00044-012-0224-6","article-title":"5-Nitro-heteroarylidene analogs of 2-thiazolyliminol-4-thiazolidinones as a novel series of antibacterial agents","volume":"22","author":"Hosseinzadeh","year":"2013","journal-title":"Med. Chem. Res."},{"key":"ref_37","first-page":"227","article-title":"3-Oxyarylthiazolidones-4 and their choleretic activity","volume":"67","author":"Nektegayev","year":"1999","journal-title":"Sci. Pharm."},{"key":"ref_38","first-page":"296","article-title":"Uber einige Amidderivate von Thiocarbonglycolsauren","volume":"Bd.I","author":"Holmberg","year":"1911","journal-title":"Chem. Zentr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prac.18770160101","article-title":"Uber die Einwirkung der Monochloressigsaure auf Sulfocyansaure und Salze","volume":"16","author":"Nencki","year":"1877","journal-title":"J. Prakt. Chem."},{"key":"ref_40","first-page":"32","article-title":"Synthesis and study of 5-alkyl derivatives of rhodanine","volume":"5","author":"Minka","year":"1963","journal-title":"Farmatsevtychnyi Zhurnal"},{"key":"ref_41","first-page":"1878","article-title":"Thiazolidine derivatives","volume":"33","author":"Kretov","year":"1963","journal-title":"Zhurnal Obshchei Khimii"},{"key":"ref_42","first-page":"663","article-title":"Substituted rhodanines and some of their aldehyde condensation products. XIII","volume":"112","author":"Andreasch","year":"1917","journal-title":"J. Chem. Soc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01524210","article-title":"New synthesis of 2,4-dioxythiazole and of its 3-phenyl derivative","volume":"38","author":"Andreasch","year":"1917","journal-title":"Monatshefte Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Abhale, Y.K., Shinde, A., Shelke, M., Nawale, L., Sarkar, D., and Mhaske, P.C. (2021). Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents. Bioorg. Chem., 115.","DOI":"10.1016\/j.bioorg.2021.105192"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"115712","DOI":"10.1016\/j.ejmech.2023.115712","article-title":"Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity","volume":"259","author":"Shawky","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1021\/jo00960a039","article-title":"Synthesis of 2-methylene-4-thiazolidinones","volume":"38","author":"Isidor","year":"1973","journal-title":"J. Org. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/prac.18740090102","article-title":"Ueber einige Derivate des Sulfoharnstoffs","volume":"9","author":"Volhard","year":"1874","journal-title":"J. Prakt. Chem."},{"key":"ref_48","first-page":"171","article-title":"Condensation and cyclization of (arylazo)chloroacetic acids. VIII. New 5-(arylhydrazono)-3-aryl-2-(arylamino)-4-thiazolidones and their oxidation and hydrolysis","volume":"3","author":"Lozinskii","year":"1971","journal-title":"Khimiya Geterotsiklicheskikh Soedin."},{"key":"ref_49","first-page":"121","article-title":"Synthesis and hydrazinolysis of 3-substituted rhodanines","volume":"3","author":"Turkevich","year":"1971","journal-title":"Khimiya Geterotsiklicheskikh Soedin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0960-894X(99)00039-6","article-title":"(3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents","volume":"9","author":"Nomura","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_51","first-page":"680","article-title":"Substitutions in the azolidine ring. XIII. Method of obtaining pseudothiohydantoin and 2,4-thiazolidinedione","volume":"27","author":"Turkevich","year":"1961","journal-title":"Ukr. Khimicheskii Zhurnal"},{"key":"ref_52","first-page":"57","article-title":"Synthesis of 2,4-dioxothiazolidine-5-acetic acid and its amides\u2014Perspective synthons for obtaining combinatorial libraries of biologically active substances","volume":"5","author":"Lesyk","year":"2001","journal-title":"Farmatsevtychnyi Zhurnal"},{"key":"ref_53","first-page":"2323","article-title":"Recyclization of 2-thioxo-1,3-thiazan-4-one and its derivatives","volume":"29","author":"Orlinskii","year":"1993","journal-title":"Zhurnal Org. Khimii"},{"key":"ref_54","first-page":"641","article-title":"Synthesis, characterization and antimicrobial evaluation of new 2-(2-thienylcarbonyl)hydrazono-3-alkyl\/aryl-4-thiazolidinone and 2-aryl-3-(2-thienylcarbonyl)amino-4-thiazolidinone derivatives","volume":"26","author":"Dincel","year":"2022","journal-title":"J. Res. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Othman, D.I.A., Hamdi, A., Abdel-Aziz, M.M., and Elfeky, S.M. (2022). Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis. Bioorg. Chem., 124.","DOI":"10.1016\/j.bioorg.2022.105809"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115757","DOI":"10.1016\/j.ejmech.2023.115757","article-title":"Pyrrole-thiazolidinone hybrids as a new structural class of broad-spectrum anti-infectives","volume":"260","author":"Ahmed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_57","first-page":"1","article-title":"In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors","volume":"42","author":"Kumari","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"115571","DOI":"10.1016\/j.ejmech.2023.115571","article-title":"Design, synthesis and biological evaljuation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B","volume":"258","author":"Cheng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/10406638.2019.1628782","article-title":"Synthesis of some novel 5-(8-substituted-11H-indolo [3,2-c]isoquinolin-5-ylthio)-1\u2032,3\u2032,4\u2032-oxadiazol-2-amines bearing thiazolidinones and azetidinones as potential antimicrobial, antioxidant, antituberculosis, and anticancer agents","volume":"41","author":"Verma","year":"2021","journal-title":"Polycycl. Aromat. Compd."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/10406638.2020.1786706","article-title":"Synthesis, biological evaluation and docking studies of some new indolyl-pyridine containing thiazolidinone and azetidinone analogs","volume":"42","author":"Verma","year":"2022","journal-title":"Polycycl. Aromat. Compd."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11094-022-02623-0","article-title":"Amtimycobacterial evaluation and microwave-assisted synthesis of N-(5-methyl-4-oxo-2-arylthiazolidin-3-yl) isonicotinamide derivatives","volume":"56","author":"Alghamdi","year":"2022","journal-title":"Pharm. Chem. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1134\/S1070363223040242","article-title":"Synthesis of novel antimicrobial indazole-linked 1,2,4-triazolylthiadiazole and 4-thiazolidinone derivatives and study of their molecular modelling","volume":"93","author":"Dunga","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5530\/jyp.2022.14.15","article-title":"Synthesis docking studies, characterization and anti-tubercular activity of ofloxacin containing thiazolidinone derivatives","volume":"14","author":"Chintakunta","year":"2022","journal-title":"J. Young Pharm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s43094-020-00162-7","article-title":"Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"7","author":"Salve","year":"2021","journal-title":"Future J. Pharm. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1570178618666210302160625","article-title":"Antimycobacterial assessment and microwave-assisted synthesis of 2-aryl-3-(4-methylphenylamino)thiazolidin-4-one derivatives","volume":"19","author":"Alghamdi","year":"2022","journal-title":"Lett. Org. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bhoge, N., Magare, B., and Mohite, P. (2023). Synthesis and biological evaluation of 3-(benzo[d]thiazol-2-yl)-2-(substituted aryl)thiazolidin-4-one derivatives. Lett. Appl. NanoBioScience, 13.","DOI":"10.33263\/LIANBS131.019"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Trawally, M., Demir-Yazici, K., Dingi\u015f-Birg\u00fcl, S.I., Kaya, K., Akdemir, A., and G\u00fczel-Akdemir, \u00d6. (2022). Mandelic acid-based spirothiazolidinones targeting M. tuberculosis: Synthesis, in vitro and in silico investigations. Bioorg. Chem., 121.","DOI":"10.1016\/j.bioorg.2022.105688"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100726","DOI":"10.1016\/j.rechem.2022.100726","article-title":"Synthesis, molecular structure investigation, biological evaluation and docking studies of novel spirothiazolidinones","volume":"5","author":"Pandey","year":"2023","journal-title":"Results Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10799893.2023.2281671","article-title":"Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine-4-one derivatives as potent anti-tubercular agents","volume":"43","author":"Moulishankar","year":"2023","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e202400054","DOI":"10.1002\/ajoc.202400054","article-title":"Pyrrole-thiazolidin-4-one analogues exhibit promising anti-tuberculosis activity","volume":"13","author":"Ahmed","year":"2024","journal-title":"Asian J. Org. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Kumar, V., Shetty, P., HS, A., Chandra, K.S., Ramu, R., Patil, S.M., Baliga, A., Rai, V.M., Shenoy, M.S., and Udupi, V. (2022). Potential fluorinated anti-MRSA thiazolidinone derivatives with antibacterial, antitubercular activity and molecular docking studies. Chem. Biodivers., 19.","DOI":"10.1002\/cbdv.202100532"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hart, D., Legoabe, L.J., Jesumoroti, O.J., Jordaan, A., Warner, D.F., Steventon, R., and Beteck, R.M. (2022). Nitrothiazole-thiazolidinone hybrids: Synthesis and in vitro antimicrobial evaluation. Chem. Biodivers., 19.","DOI":"10.1002\/cbdv.202200729"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e2200444","DOI":"10.1002\/ardp.202200444","article-title":"Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybrids","volume":"356","author":"Kamat","year":"2023","journal-title":"Arch. Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jccs.202000166","article-title":"Novel thiazolidin-4-one clubbed thiophene derivatives via Gewald synthesis as anti-tubercular and anti-inflammatory agents","volume":"68","author":"Nayak","year":"2021","journal-title":"J. Chin. Chem. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e202303188","DOI":"10.1002\/slct.202303188","article-title":"2,3,5-Trisubstituted thiazolidinone derivatives as potential antimicrobial and antitubercular agents and in silico studies","volume":"9","author":"Nefisath","year":"2024","journal-title":"ChemistrySelect"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1570162X20666220512163049","article-title":"One-pot synthesis of novel hydrazono-1,3-thiazolidin-4-one derivatives as anti-HIV and anti-tubercular agents: Synthesis, biological evaluation, molecular modelling and admet studies","volume":"20","author":"Pasha","year":"2022","journal-title":"Curr. HIV Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Younis, M.H., Mohammed, E.R., Mohamed, A.R., Abdel-Aziz, M.M., Georgey, H.H., and Gawad, N.M.A. (2022). Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives. Bioorg. Chem., 124.","DOI":"10.1016\/j.bioorg.2022.105807"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1134\/S1068162021010027","article-title":"Antimycobacterial activity, in silico ADME evaluation, and docking study of novel thiazolidinedione and imidazolidinone conjugates","volume":"47","author":"Angelova","year":"2021","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_79","first-page":"643","article-title":"Synthesis, in vitro antiproliferative and antimycobacterial activity of thiazolidine-2,4-dione and hydantoin derivatives","volume":"49","author":"Angelova","year":"2017","journal-title":"Bulg. Chem. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2442703","DOI":"10.1080\/14756366.2024.2442703","article-title":"The new thiazolidine-2,4-dione-based hybrids with promising antimycobacterial activity: Design, synthesis, biological evaluation, and drug interaction analysis","volume":"40","author":"Trotsko","year":"2025","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"114831","DOI":"10.1016\/j.ejmech.2022.114831","article-title":"Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function","volume":"244","author":"Dak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Raghu, M.S., Kumar, C.B.P., Yogesh Kumar, K., Prashanth, M.K., Alharethy, F., and Jeon, B.-H. (2024). Synthesis, biologicalevaluation and molecular docking study of pyrimidine linked thiazolidinedione derivatives as potential antimicrobial and antitubercular agents. Bioorg. Med. Chem. Lett., 103.","DOI":"10.1016\/j.bmcl.2024.129707"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e2400064","DOI":"10.1002\/ardp.202400064","article-title":"Exploring rhodanine linked enamine-carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies","volume":"357","author":"Maddipatla","year":"2024","journal-title":"Arch. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2018.01.047","article-title":"An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors","volume":"146","author":"Chollet","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"40659","DOI":"10.1021\/acsomega.2c05307","article-title":"Recent advances of DprE1 inhibitors against Mycobacterium tuberculosis: Computational analysis of physicochemical and ADMET properties","volume":"7","author":"Amado","year":"2022","journal-title":"ACS Omega"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e202300099","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 Inhibitors: Enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.str.2020.12.002","article-title":"Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states","volume":"29","author":"Liang","year":"2021","journal-title":"Structure"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37098","DOI":"10.1039\/D0RA07398A","article-title":"Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis\u2014A medicinal chemist perspective","volume":"10","author":"Suresh","year":"2020","journal-title":"RSC Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","article-title":"Mycolic acids: Structures, biosynthesis, and beyond","volume":"21","author":"Marrakchi","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/mdr.2021.0424","article-title":"Molecular mechanisms of MmpL3 function and inhibition","volume":"29","author":"Williams","year":"2023","journal-title":"Microb. Drug Resist."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e202403715","DOI":"10.1002\/slct.202403715","article-title":"Molecular docking simulation and ADMET\/pharmacokinetic screening of newly designed 2-(2-aryl-4-oxo-4,5-dihydrothiazol-5-yl)acetohydrazides as potential antitubercular agents","volume":"9","author":"Sajid","year":"2024","journal-title":"ChemistrySelect"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"132278","DOI":"10.1016\/j.molstruc.2021.132278","article-title":"Novel benzoic thiazolidin-4-one derivatives targeting DevR\/DosR dormancy regulator of Mycobacterium tuberculosis","volume":"1254","author":"Sharma","year":"2022","journal-title":"J. Mol. Struct."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/10\/2201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:34:35Z","timestamp":1760031275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/10\/2201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["molecules30102201"],"URL":"https:\/\/doi.org\/10.3390\/molecules30102201","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]}}}